Viia Valge-Archer

5.3k citations

27 papers · 2.4k indexed · h-index 19

Immunology top 2%
Molecular Biology top 10%
Oncology top 2%
Cancer Research top 5%
Radiology, Nuclear Medicine and Imaging top 5%

Co-authors: Anjana Rao Jugnu Jain Janice M. Reichert Patricia G. McCaffrey Terence H. Rabbitts A. Förster Helen K. Angell Franck Pagès
Topics: Immune Cell Function and Interaction (11 papers)Cancer Immunotherapy and Biomarkers (8 papers)T-cell and B-cell Immunology (6 papers)
Cited by: Immunology Oncology Cancer Research
Journals: Nature Proceedings of the National Academy of Sciences Nucleic Acids Research
Partner nations: United Kingdom United States Singapore

In The Last Decade

Viia Valge-Archer

26 papers receiving 2.4k citations

Peers

Countries citing papers authored by Viia Valge-Archer

Since Specialization

Citations

This map shows the geographic impact of Viia Valge-Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viia Valge-Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viia Valge-Archer more than expected).

Fields of papers citing papers by Viia Valge-Archer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viia Valge-Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viia Valge-Archer. The network helps show where Viia Valge-Archer may publish in the future.

Co-authorship network of co-authors of Viia Valge-Archer

This figure shows the co-authorship network connecting the top 25 collaborators of Viia Valge-Archer. A scholar is included among the top collaborators of Viia Valge-Archer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viia Valge-Archer. Viia Valge-Archer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PARP inhibition generates enhanced CD8+ central memory T cells by transcriptional and metabolic reprogramming 2026 ·Nature Immunology ·(unknown),(unknown),Subhadip Kundu,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Mikayel Mkrtichyan,Viia Valge-Archer,(unknown),Vivek Verma,(unknown),(unknown)	0
2	Age-induced changes in anti-tumor immunity alter the tumor immune infiltrate and impact response to immuno-oncology treatments 2023 ·Frontiers in Immunology ·(unknown),Jennifer A. Walker,(unknown),Michelle Morrow,Viia Valge-Archer,Matthew J. Robinson,Robert W. Wilkinson,Simon J. Dovedi	9
3	Small Gene Networks Delineate Immune Cell States and Characterize Immunotherapy Response in Melanoma 2023 ·Cancer Immunology Research ·(unknown),(unknown),(unknown),(unknown),Simon J. Dovedi,Viia Valge-Archer,Amit Grover,Robert W. Wilkinson,(unknown),Claus Bendtsen,Ian P. Barrett,Donal J. Brennan,Walter Kölch,Vadim Zhernovkov	2
4	Discovery and characterisation of quinazolines and 8-Azaquinazolines as NLRP3 agonists with oral bioavailability in mice 2023 ·Bioorganic & Medicinal Chemistry Letters ·Daniel H. O’Donovan,David Baker,Giovanni Ciotta,Sébastien L. Degorce,(unknown),(unknown),Leire Escudero‐Ibarz,Lucy Ireland,Yumeng Mao,Martin J. Packer,James Robinson,Graeme Scarfe,Haoran Tang,Viia Valge-Archer	1
5	PARP inhibition is a modulator of anti-tumor immune response in BRCA-deficient tumors 2022 ·OncoImmunology ·Anna D. Staniszewska,Joshua Armenia,Matthew King,Chrysiis Michaloglou,(unknown),Maneesh Singh,Maryann San Martin,(unknown),Zena Wilson,Theresa A. Proia,Deanna L. Russell,Morgan Thomas,Oona Delpuech,Mark J. O’Connor,Elisabetta Leo,Helen K. Angell,Viia Valge-Archer	37
6	Inhibition of DNA-PK with AZD7648 Sensitizes Tumor Cells to Radiotherapy and Induces Type I IFN-Dependent Durable Tumor Control 2021 ·Clinical Cancer Research ·Kyoko Nakamura,Ankur Karmokar,Paul Farrington,Neil H. James,Antonio Ramos‐Montoya,(unknown),Gareth Hughes,Tim Illidge,Elaine Cadogan,Barry R. Davies,Simon J. Dovedi,Viia Valge-Archer	43
7	Dissecting the Role of BET Bromodomain Proteins BRD2 and BRD4 in Human NK Cell Function 2021 ·Frontiers in Immunology ·Adam P. Cribbs,P. Filippakopoulos,Martin Philpott,Graham Wells,Henry Penn,Henrik Oerum,Viia Valge-Archer,Marc Feldmann,Udo Oppermann	19
8	A cell-engineered system to assess tumor cell sensitivity to CD8 ⁺ T cell-mediated cytotoxicity 2019 ·OncoImmunology ·(unknown),(unknown),Asís Palazón,Edmund Poon,Maike de la Roche,Simon T. Barry,Viia Valge-Archer,Robert W. Wilkinson,Simon J. Dovedi,Paul D. Smith	21
9	MHC class I chain-related protein A and B (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue 2017 ·British Journal of Cancer ·Hormas Ghadially,Lee R. Brown,Chris J. Lloyd,(unknown),Arthur Lewis,Janette Dillon,Richard C.A. Sainson,Jelena Arambašić Јovanović,Natalie J. Tigue,David Bannister,Lisa Bamber,Viia Valge-Archer,Robert W. Wilkinson	83
10	A high density of tertiary lymphoid structure B cells in lung tumors is associated with increased CD4⁺T cell receptor repertoire clonality 2015 ·OncoImmunology ·Wei Zhu,Claire Germain,(unknown),Yinong Sebastian,Priyanka Devi-Marulkar,Samantha Knockaert,Philip Z. Brohawn,Kim Lehmann,Diane Damotte,Pierre Validire,Yihong Yao,Viia Valge-Archer,Scott A. Hammond,Marie‐Caroline Dieu‐Nosjean,Brandon W. Higgs	86
11	The impact of cellular senescence and DNA damage on colorectal tumour progression 2013 ·Journal for ImmunoTherapy of Cancer ·Helen K. Angell,Marie Tosolini,Bernhard Mlecnik,Gabriela Bindea,Tessa Fredriksen,Lucie Lafontaine,Maximilian J. Waldner,Franck Pagès,Viia Valge-Archer,Jérôme Galon	1
12	In vitro potency, pharmacokinetic profiles and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus 2010 ·mAbs ·Yulia Vugmeyster,Heath Guay,Pamela Szklut,(unknown),(unknown),Angela Widom,Vikki Spaulding,Frann Bennett,Leslie Lowe,Tatyana Andreyeva,David C. Lowe,Steven Lane,George Thom,Viia Valge-Archer,Davinder Gill,Deborah Young,Laird Bloom	33
13	Development trends for monoclonal antibody cancer therapeutics 2007 ·Nature Reviews Drug Discovery ·Janice M. Reichert,Viia Valge-Archer	289
14	The LMO1 and LDB1 proteins interact in human T cell acute leukaemia with the chromosomal translocation t(11;14)(p15;q11) 1998 ·Oncogene ·Viia Valge-Archer,A. Förster,Terence H. Rabbitts	31
15	The LIM protein RBTN2 and the basic helix-loop-helix protein TAL1 are present in a complex in erythroid cells. 1994 ·Proceedings of the National Academy of Sciences ·Viia Valge-Archer,(unknown),Alan J. Warren,A. Förster,(unknown),Richard Baer,Terence H. Rabbitts	178
16	Cyclosporin A sensitivity of the NF-χB site of the IL2Rα promoter in untransformed murine T cells 1994 ·Nucleic Acids Research ·Patricia G. McCaffrey,Peter K. Kim,Viia Valge-Archer,Ranjan Sen,Anjana Rao	40
17	The AP-1 site at -150 bp, but not the NF-kappa B site, is likely to represent the major target of protein kinase C in the interleukin 2 promoter. 1992 ·The Journal of Experimental Medicine ·Jugnu Jain,Viia Valge-Archer,Anthony J. Sinskey,Anjana Rao	66
18	Analysis of the AP-1 sites in the IL-2 promoter 1992 ·The Journal of Immunology ·Jugnu Jain,Viia Valge-Archer,Anjana Rao	166
19	Nuclear factor of activated T cells contains Fos and Jun 1992 ·Nature ·Jugnu Jain,Patricia G. McCaffrey,Viia Valge-Archer,Anjana Rao	445
20	Transformation of T lymphocytes by the v- fos oncogene. 1990 ·The Journal of Immunology ·Viia Valge-Archer,(unknown),Anthony J. Sinskey,Anjana Rao	15

About Viia Valge-Archer

Viia Valge-Archer is a scholar working on Immunology, Oncology and Cancer Research, having authored 27 papers that have together received 2.4k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (11 papers), Cancer Immunotherapy and Biomarkers (8 papers) and T-cell and B-cell Immunology (6 papers). The work is most often cited by research in Immunology (1.2k citations), Oncology (1.0k citations) and Cancer Research (373 citations). Viia Valge-Archer has collaborated with scholars based in United Kingdom, United States and Singapore. Frequent co-authors include Anjana Rao, Jugnu Jain, Janice M. Reichert, Patricia G. McCaffrey, Terence H. Rabbitts, A. Förster, Helen K. Angell, Franck Pagès, Bernhard Mlecnik and Anne Berger. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact